RHY 4.11% 7.0¢ rhythm biosciences limited

Ann: CE Mark Granted for ColoSTAT, page-41

  1. 757 Posts.
    lightbulb Created with Sketch. 102
    'ColoSTAT is a threat to Sonic's current business as it can wipe out the FIT market which Sonic plays in' - I'd rather say that RHY is becoming T/O target for SHL
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.